---
document_datetime: 2024-05-07 09:40:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/emblaveo-epar-all-authorised-presentations_en.pdf
document_name: emblaveo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6732117
conversion_datetime: 2025-12-19 06:30:37.322951
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength      | Pharmaceutical Form                              | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|---------------|--------------------------------------------------|---------------------------|-----------------------|-------------|
| EU/1/24/1808/001 | Emblaveo          | 1.5 g / 0.5 g | Powder for concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 vials    |